EWP 815

立即咨询

EWP 815

本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。

CAS NO:

20231-01-0

包装与价格：

包装	价格(元)
25mg	询价
50mg	询价
100mg	询价

EWP 815 是一种二硫类似物，是Ins(1,4)P₂磷酸酶和Ins(1,4,5)P₃5-磷酸酶的有效抑制剂。EWP 815 也参与抑制体内多巴胺酶 β-羟化酶活性。

生物活性

EWP 815 is a disulfiram analogue, is a potent inhibitor ofIns(1,4)P₂phosphataseandIns(1,4,5)P₃5-phosphatase. EWP 815 also inhibits enzymedopamine β-hydroxylaseactivity^[1]^[2].

IC₅₀& Target

Ins(1,4)P2 phosphatase; Ins(1,4,5)P3 5-phosphatase^[1]; dopamine β-hydroxylase^[2]

体外研究
(In Vitro)

EWP 815 inhibits thyrotropin-releasing hormone (TRH; 0.03 mM)-stimulated inositol phospholipid breakdown without affecting basal breakdown rates in prelabelled GH₃cells with IC₅₀s of 83 mM (soluble enzymes) and 71 mM (particulate enzymes), respectively^[1].
EWP 815 (30 μM; 1 h) exerts higher inhibition on Ins(1,4)P₂phosphatase rather than Ins(1,4,5)P₃5-phosphatase with the mean [³H]Ins(1,4)P₂/mean [³H]InsPrecovery ratio of 2.6^[1].
EWP 815 (6, 8 μM; 10 min) inhibits dephosphorylation of [³H]Ins(1,4,5)P₃5-phosphatase in particulate and soluble fractions with IC₅₀s of 6 μM and 8 μM, respectively^[1].
EWP 815 (3-300 μM; 30 min) suppresses thyrotropin-releasing hormone (TRH)-stimulated (100 nM) inositol phospholipid production by 30% (100 μM) and 1.8% (300 μM), respectively, without affecting Ins(1,4,5)P₃binding^[1].

体内研究
(In Vivo)

EWP 815 (50 mg/kg; i.p.; 30 min before killed) inhibits the enzyme dopamine β-hydroxylase activity in mice^[2].

Animal Model:	Female mice (20 g)^[2]
Dosage:	50 mg/kg
Administration:	Intraperitoneal injection; 30 min before killed
Result:	Intraperitoneal injection; 30 min before killedInhibited β-hydroxylase of³H-α-methyldopamine. Reduced the amount of³H-α-Me-NA by 12%.

分子量

350.59

Formula

C₁₂H₂₂N₄S₄

CAS 号

20231-01-0

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.